Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PI103 | 0.1 | uM | TNF-a | 100 | ng/mL | 4 | IFN-a2 | 176.5 | 60 | |
N2586 | Sigma A6730 | 3.0 | uM | TNF-a | 100 | ng/mL | 4 | IFN-a2 | 227.0 | 39 | |
N2586 | JNK-IN-8 | 3.0 | uM | TNF-a | 100 | ng/mL | 4 | IFN-a2 | 165.0 | 54 | |
N2586 | JNK-IN-11 | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | IFN-a2 | 36.0 | 55 | |
N2586 | PD184352 | 0.1 | uM | 4 | IFN-a2 | 47.0 | 48 | ||||
0 | IFN-a2 | 13.0 | 57 | ||||||||
RA2159 | 4 | IFN-a2 | 21.0 | 62 | |||||||
RA2159 | EO1428 | 1.0 | uM | 4 | IFN-a2 | 18.5 | 54 | ||||
RA2159 | PI103 | 0.1 | uM | 4 | IFN-a2 | 23.0 | 61 | ||||
RA2159 | Sigma A6730 | 3.0 | uM | 4 | IFN-a2 | 20.0 | 60 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 4 | IFN-a2 | 23.0 | 79 | ||||
RA2159 | JNK-IN-11 | 0.3 | uM | 4 | IFN-a2 | 19.0 | 61 | ||||
RA2159 | 4 | IFN-a2 | 21.0 | 50 | |||||||
N2586 | 4 | IFN-a2 | 50.0 | 67 | |||||||
N2586 | EO1428 | 1.0 | uM | 4 | IFN-a2 | 53.0 | 51 | ||||
N2586 | PI103 | 0.1 | uM | 4 | IFN-a2 | 44.0 | 47 | ||||
N2586 | Sigma A6730 | 3.0 | uM | 4 | IFN-a2 | 51.0 | 52 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 4 | IFN-a2 | 37.0 | 61 | ||||
N2586 | JNK-IN-11 | 0.3 | uM | 4 | IFN-a2 | 34.0 | 57 | ||||
N2586 | 4 | IFN-a2 | 48.5 | 50 | |||||||
TNF-a | 100 | ng/mL | 0 | IFN-a2 | 16.0 | 59 | |||||
IL-1 alpha | 100 | ng/mL | 0 | IFN-a2 | 19.5 | 50 | |||||
IL-6 | 100 | ug/mL | 0 | IFN-a2 | 19.0 | 41 | |||||
IL-17A | 100 | ng/mL | 0 | IFN-a2 | 17.0 | 70 | |||||
EGF | 100 | ng/mL | 0 | IFN-a2 | 18.5 | 48 |